Vital Farms

VITL · NASDAQ

$8.21+$0.05 (+0.61%)TodayMarket closed · Oct 20, 7:43 PM ET

Prev close $8.16

VITL analyst rating

HoldConsensus of 13 analysts over the last 12 months. 46% rate it a buy.

Strong buy0
Buy6
Hold7
Underperform0
Sell0

12-month price target · 11 analysts

Average $13.49 (+64.3% upside)

Low: $10.10
Now: $8.21
High: $18.90

Upgrades and downgrades

The latest rating actions, newest first

VITL analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Stifel	Oct 15, 2026	Maintains	Hold	$11.00 → $9.00	41%
TD Cowen	Oct 13, 2026	Maintains	Hold	$11.00 → $8.00	58%
Needham	Sep 17, 2026	Maintains	Buy	$14.00	32%
DA Davidson	Aug 7, 2026	Maintains	Neutral	$16.00 → $14.00	18%
TD Cowen	Aug 7, 2026	Maintains	Hold	$10.00 → $11.00	58%
Needham	Aug 7, 2026	Maintains	Buy	$13.00 → $14.00	32%
Needham	May 11, 2026	Maintains	Buy	$20.00 → $13.00	32%
William Blair	May 8, 2026	Downgrade	Outperform → Market Perform	—	33%
Stifel	May 8, 2026	Downgrade	Buy → Hold	$34.00 → $10.00	41%
DA Davidson	May 4, 2026	Downgrade	Buy → Neutral	$47.00 → $16.00	33%

The case for and against

Updated Oct 14, 2026

Bull case

Vital Farms is attractive because it combines a scaled premium brand with an ethically sourced, clean-label value proposition that can expand household penetration as consumer interest deepens. The company still expects $775-$800 million of revenue this year, and management reiterated FY26 guidance while signaling 2Q as a trough, with sequential improvement expected from lower breaker-channel losses, better retail volumes, and a return to roughly 30% gross margin exiting FY26. A major liquidity reset also strengthens the thesis: $185 million of available liquidity from new credit facilities, plus $6-$7 million of annualized SG&A savings, gives it time to stabilize profitability, reduce earnings volatility, and improve operating leverage.

Bear case

Vital Farms is facing a fundamentally pressured setup as 2Q net sales fell 10% to $166 million, driven by a 10.7% volume decline that outweighed modest price/mix gains, while gross margin collapsed to 6.6% and adjusted EBITDA showed a $26.6 million loss. The company’s outlook is further weakened by heavy customer concentration, with about 40% of revenue tied to two customers, plus reliance on a fragile supply chain, volatile commodity and packaging costs, and sole-source carton exposure that can quickly impair profitability and liquidity. At the same time, costly capacity expansion, inventory missteps, and limited ability to secure covenant relief or alternative financing could amplify downside if demand softens or competition intensifies.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.